Literature DB >> 8388505

Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons.

M A Khan1, W H Tolleson, J D Gangemi, L Pirisi.   

Abstract

We used a model system of normal human keratinocytes (HKc) and HKc immortalized with human papillomavirus type 16 DNA (HKc/HPV16) to investigate the effects of alpha interferons (IFN-alpha) on the growth of HPV16-immortalized human epithelial cells, on HPV16-mediated immortalization of normal HKc, and on HPV16 gene expression. Normal HKc and HKc/HPV16 were treated with several recombinant human IFN-alpha subtypes (IFN-alpha B, IFN-alpha D, and IFN-alpha B/D). These IFN-alpha subtypes inhibited proliferation of both normal HKc and HKc/HPV16 in a dose-dependent fashion; however, although 1,000 to 10,000 U of IFN-alpha per ml were required to inhibit growth of normal HKc, HKc/HPV16 were substantially growth inhibited by 100 U/ml. In addition, 100 U of IFN-alpha B/D per ml inhibited transformation of normal HKc by HPV16 DNA. Northern (RNA) blot analysis showed no effect of IFN-alpha on the mRNA levels of the HPV16 E6 and E7 open reading frames. However, immunofluorescence studies of the HPV16 E6 and E7 proteins with anti-E6 and anti-E7 monoclonal antibodies showed significant inhibition of E7 protein expression in cells treated with IFN-alpha, whereas E6 protein expression was not altered. The inhibition of E7 protein expression in cells treated with IFN-alpha was further confirmed by Western immunoblot analysis. These results suggest that IFN-alpha may inhibit HPV16-mediated transformation of HKc and proliferation of HKc/HPV16 through an inhibition of HPV16 E7 protein expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388505      PMCID: PMC237683     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames.

Authors:  P Kaur; J K McDougall; R Cone
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

Review 2.  Interferon.

Authors:  K F Trofatter
Journal:  Obstet Gynecol Clin North Am       Date:  1987-06       Impact factor: 2.844

3.  Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections.

Authors:  J D Gangemi; A Matter; B Poncioni; H K Hochkeppel
Journal:  J Interferon Res       Date:  1989-06

4.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

5.  Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?

Authors:  P G Fuchs; F Girardi; H Pfister
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

6.  Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid.

Authors:  J D Gangemi; J Lazdins; F M Dietrich; A Matter; B Poncioni; H K Hochkeppel
Journal:  J Interferon Res       Date:  1989-04

7.  Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes.

Authors:  M A Khan; G R Jenkins; W H Tolleson; K E Creek; L Pirisi
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

8.  Characterization of primary human keratinocytes transformed by human papillomavirus type 18.

Authors:  P Kaur; J K McDougall
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA.

Authors:  L Pirisi; K E Creek; J Doniger; J A DiPaolo
Journal:  Carcinogenesis       Date:  1988-09       Impact factor: 4.944

10.  Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.

Authors:  T Crook; J P Morgenstern; L Crawford; L Banks
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  10 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication.

Authors:  Paramananda Saikia; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 3.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

4.  Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined.

Authors:  Xiuning Le; Ehab Y Hanna
Journal:  Ann Transl Med       Date:  2018-06

5.  Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.

Authors:  Anastasia Bachmann; Brigitte Hanke; Rainer Zawatzky; Ubaldo Soto; Jan van Riggelen; Harald zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.

Authors:  Amy Baldwin; Lucia Pirisi; Kim E Creek
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1.

Authors:  Fulvia Terenzi; Paramananda Saikia; Ganes C Sen
Journal:  EMBO J       Date:  2008-11-13       Impact factor: 11.598

8.  Interferon-Tau has Antiproliferative effects, Represses the Expression of E6 and E7 Oncogenes, Induces Apoptosis in Cell Lines Transformed with HPV16 and Inhibits Tumor Growth In Vivo.

Authors:  Herbey Oswaldo Padilla-Quirarte; Cesar Trejo-Moreno; Geny Fierros-Zarate; Jhoseline Carnalla Castañeda; Marie Palma-Irizarry; Eva Hernández-Márquez; Ana Isabel Burguete-Garcia; Oscar Peralta-Zaragoza; Vicente Madrid-Marina; Kirvis Torres-Poveda; Victor Hugo Bermúdez-Morales
Journal:  J Cancer       Date:  2016-11-05       Impact factor: 4.207

Review 9.  Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.

Authors:  Marconi Rego Barros; Talita Helena Araújo de Oliveira; Cristiane Moutinho Lagos de Melo; Aldo Venuti; Antonio Carlos de Freitas
Journal:  J Immunol Res       Date:  2018-05-02       Impact factor: 4.818

Review 10.  Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence.

Authors:  Eva H Clark; Robert H Gilman; Elizabeth Y Chiao; Patti E Gravitt
Journal:  Am J Trop Med Hyg       Date:  2021-07-19       Impact factor: 3.707

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.